# Primary Resistance Mechanisms of ALK TKIs

> **NCT07045610** · — · NOT_YET_RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 20 (estimated)

## Conditions studied

- ALK-positive Advanced NSCLC Patients
- Primary Resistance
- NGS

## Interventions

- **DIAGNOSTIC_TEST:** re-biopsy tumor with primary ALK tKI resistance for NGS

## Key facts

- **NCT ID:** NCT07045610
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2027-07-01
- **Final completion:** 2028-07-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07045610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07045610, "Primary Resistance Mechanisms of ALK TKIs". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07045610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*